Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Raw Materials (2016 - 2025)

Collegium Pharmaceutical has reported Raw Materials over the past 10 years, most recently at $8.3 million for Q3 2025.

  • Quarterly results put Raw Materials at $8.3 million for Q3 2025, up 98.31% from a year ago — trailing twelve months through Sep 2025 was $8.3 million (up 98.31% YoY), and the annual figure for FY2024 was $12.5 million, up 20.68%.
  • Raw Materials for Q3 2025 was $8.3 million at Collegium Pharmaceutical, down from $9.5 million in the prior quarter.
  • Over the last five years, Raw Materials for COLL hit a ceiling of $14.4 million in Q3 2023 and a floor of $3.7 million in Q4 2021.
  • Median Raw Materials over the past 5 years was $7.2 million (2024), compared with a mean of $7.7 million.
  • Biggest five-year swings in Raw Materials: surged 149.84% in 2023 and later tumbled 70.8% in 2024.
  • Collegium Pharmaceutical's Raw Materials stood at $3.7 million in 2021, then soared by 51.97% to $5.6 million in 2022, then surged by 85.43% to $10.4 million in 2023, then rose by 20.68% to $12.5 million in 2024, then crashed by 33.48% to $8.3 million in 2025.
  • The last three reported values for Raw Materials were $8.3 million (Q3 2025), $9.5 million (Q2 2025), and $11.8 million (Q1 2025) per Business Quant data.